Information  X 
Enter a valid email address

Assura plc (AGR)


Friday 18 March, 2022

Assura plc

Scrip Calculation Price

RNS Number : 3205F
Assura PLC
18 March 2022


18 March 2022


Assura plc


Scrip Calculation Price

Assura plc ("the Company") announces, in accordance with the terms and conditions of the Company's Scrip Dividend Scheme ("the Scheme"), that the Scrip Calculation Price in respect of the quarterly interim dividend proposed to be paid on 13 April 2022, is 67.52 pence. This is the average closing mid-market price of an ordinary share in the Company for the five dealing days commencing with, and including, the ex-dividend date of 10 March 2022.

If you wish to receive this quarterly interim dividend in cash, you do not need to take any action.


If you wish to participate in the Scheme and receive New Shares instead of your cash dividend, you should complete a Mandate, as follows:


· If you hold your Ordinary Shares in certificated form, and if you have not already done so, you should complete the Mandate Form (which is available to download from Assura's website in accordance with the instructions printed thereon and return it to Link Group at 10th Floor, Central Square, 29 Wellington Street, Leeds, LS1 4DL by no later than 4.30 p.m. (London time) on 31 March 2022. The Mandate Form will remain in force for any future dividends in respect of which a Scrip Dividend Alternative is offered, until such time as the Mandate Form is cancelled.


· If you hold your Ordinary Shares in uncertificated form via the CREST System, you can only elect to receive dividends in the form of New Shares by submitting a CREST Dividend Election Input Message via the CREST System. Evergreen elections will not be permitted. This means that if you wish to receive New Shares instead of cash as a matter of routine whenever a Scrip Dividend Alternative is offered, you must complete and submit a CREST Dividend Election Input Message on each occasion, otherwise you will receive the relevant dividend in cash.


If you have any questions about the Scheme or how it operates, you can contact our Registrar, Link Group, at the address above or by telephone on 0371 664 0321. Lines are open between 9.00am and 5.30pm Monday to Friday, excluding public holidays.


Based upon the above Scrip Calculation Price, if all eligible Shareholders were to elect to take up their full entitlement to New Shares in respect of this quarterly interim dividend, approximately 32,313,183 New Shares would be issued. This would represent approximately 1 per cent. of the Company's issued share capital as at today's date. The total cash cost of this quarterly interim dividend if no Shareholders were to elect to take up their entitlement (and therefore no New Shares were to be issued) would be approximately £21.8 million.


Words and expressions defined in the circular dated 9 December 2015 in relation to the Scheme bear the same meanings in this announcement.


This interim dividend will be paid as 100% Property Income Distribution ("PID"). F orms to register for gross PIDs are available on the Company's website. Please click here for PID Forms .


- Ends -


For more information, please contact:


Assura plc


Tel: 01925 945354

Orla Ball, Company Secretary

David Purcell, Head of Investor Relations


Email: [email protected]



Gordon Simpson
James Thompson

Tel: 0207 251 3801

Email: [email protected]


Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2021, Assura's property portfolio was valued at 2,595 million.


Further information is available at

* EPRA is a registered trademark of the European Public Real Estate Association  


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t